🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2010-03
Trial ID
NCT01089127
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02238106
This study was designed to test the following hypothesis: The acute change...
Status
Completed
Location
Hôpital Laval
Start Date
2006-05
Trial ID
NCT00525564
Treatments Being Tested
The purpose of this study is to determine whether patients with asthma who ...
Status
Completed
Location
Maternal and Child Health Sciences, Ninewells Hospital and Medical School
Start Date
2007-08
Trial ID
NCT00655616
Treatments Being Tested
Τherapeutic equivalence, randomized, multiple-dose, placebo-controlled, obs...
Status
Completed
Location
BECRO Ltd.
Start Date
2018-10-02
Trial ID
NCT03676413